2-27827722-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_022128.3(RBKS):c.640G>A(p.Ala214Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000131 in 1,608,250 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_022128.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152066Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000181 AC: 44AN: 243712Hom.: 0 AF XY: 0.000204 AC XY: 27AN XY: 132160
GnomAD4 exome AF: 0.000128 AC: 186AN: 1456184Hom.: 0 Cov.: 31 AF XY: 0.000146 AC XY: 106AN XY: 724732
GnomAD4 genome AF: 0.000158 AC: 24AN: 152066Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74286
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 20, 2024 | The c.640G>A (p.A214T) alteration is located in exon 7 (coding exon 7) of the RBKS gene. This alteration results from a G to A substitution at nucleotide position 640, causing the alanine (A) at amino acid position 214 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at